Bionano Genomics Inc. logo

Bionano Genomics Inc.

BNGO | NASDAQ
Chart Builder DCF Calculator
$1.83
+$0.10 (+5.78%)
At close: Sep 21, 2026, 4:00 PM ET
$1.87
+$0.04 (+2.19%)
After-hours: Sep 21, 2026, 7:56 PM ET

Market Data

Market Cap
$19.85M
Enterprise Value
$17.78M
Beta
1.65
Average Volume
148.64K
Shares Outstanding (Diluted)
11.55M
Shares Change YoY
235.54%
Institutional Ownership
7.93%
Exchange
NASDAQ
ISIN
US09075F4046

Price Performance

Price Change 1M
50.0%
Price Change 3M
59.1%
Price Change 6M
52.5%
Price Change YTD
15.1%
Price Change 1Y
4.0%
Price Change 3Y
-99.0%
Price Change 5Y
-99.9%
1M CAGR (ann.)
57.3%
1Y CAGR (ann.)
-2.3%
5Y CAGR (ann.)
-78.0%
All-Time CAGR
-61.3%

Valuation

PE Ratio
-0.41
Forward PE
N/A
PEG Ratio
-0.00
Forward PEG
0.01
PS Ratio
0.70
Forward PS
0.50
PB Ratio
0.66
P/FCF Ratio
-1.03
P/Adj. FCF Ratio
-0.88
P/OCF Ratio
-1.03
EV/Sales
0.59
EV/EBIT
-0.56
EV/EBITDA
-0.79
EV/FCF
-0.87
Earnings Yield
-243.2%
FCF Yield
-97.5%
Adj. FCF Yield
-114.2%

Financial Health

Net Cash
$9.92M
Total Debt
$6.7M
Cash & Short-Term Investments
$9.92M
Total Assets
$47.59M
Current Ratio
2.48
Quick Ratio
1.96
Debt / Equity Ratio
0.21
Debt / EBITDA
-0.30
Debt / FCF
-0.33
OCF / Debt
-3.05
Interest Coverage
-151.12
Altman Z-Score
-22.09
Piotroski F-Score
5

Margins & Profitability

Gross Profit Margin
47.5%
Operating Profit Margin
-106.7%
EBITDA Margin
-74.3%
Net Profit Margin
-106.6%
FCF Margin
-67.9%
Adj. FCF Margin
-79.5%
SBC / Revenue
11.6%
SBC Impact (per share)
-17.1%

Returns

Return on Assets
-67.6%
Return on Equity
-78.8%
Return on Invested Capital
-83.8%
Return on Capital Employed
-85.7%
Return on Tangible Assets
-70.0%

Historical Growth (CAGR)

Revenue CAGR 3Y
-1.4%
Revenue CAGR 5Y
18.0%
Revenue CAGR 10Y
N/A
EPS CAGR 3Y
149.5%
EPS CAGR 5Y
47.5%
EPS CAGR 10Y
N/A
FCF CAGR 3Y
84.8%
FCF CAGR 5Y
36.0%
FCF CAGR 10Y
N/A

Analyst Forecasts

Analyst Rating
Buy
Analyst Count
7
EPS Growth Next 3Y
31.5%
Revenue Growth Next 3Y
30.1%
Earnings Date
N/A
EPS Estimate (next Q)
N/A
EPS Growth Est (next Q)
N/A
Revenue Est (next Q)
N/A
Revenue Growth Est (next Q)
N/A

Fair Value Estimates

Graham Number
N/A
Graham Upside
N/A
Lynch Fair Value
N/A
Lynch Upside
N/A
Price Target
$46.50
Price Target Upside
2441.0%

Cash Flow

Operating Cash Flow
$-20.48M
Free Cash Flow
$-20.48M
Adj. Free Cash Flow
$-23.99M
FCF Per Share
-$1.77
OCF Per Share
-$1.77
OCF/S Ratio
-67.9%

Income Statement

Revenue
$30.18M
Gross Profit
$14.34M
Operating Income
$-32.19M
EBITDA
$-22.41M
Net Income
$-32.16M
EPS (Diluted)
-$4.45
Revenue / Employee
$314.33K
Profit / Employee
$-335.02K
Employees
96

© 2026 bestshares.com. All rights reserved.